Former Members

Our laboratory is deeply committed to the development and training of the next generation of research scientists, supporting individuals at all stages of their careers, from undergraduate and master’s students to Ph.D. candidates and postdoctoral researchers. To maximize this process, we actively promote cross-level interactions and co-supervision within the team. Whether by integrating early-stage students into ongoing projects or empowering junior and senior researchers to launch new research lines, our goal is to foster curiosity, motivation, and a lasting passion for cancer research.

  • Postdoctoral fellows

    • Laura Devis Jauregui, PhD

      Postdoctoral fellow 2018-2022

      Image alt
      Ramón y Cajal principal investigator at University of Barcelona.

    • Ricard Bonilla, PhD

      Postdoctoral fellow 2025

      Image alt
      Postdoctoral researcher at Universitat Pompeu Fabra (Ana Janic’s Lab), Barcelona. SP.

  • PhD Students

    • Meredith Leigh Davis, PhD

      PhD student 2016-2020

      Image alt
      Postdoctoral Associate at Duke University, Department of Pathology (Ming Chen’s Lab), North Carolina. USA.

    • Berta Roman Canal, PhD

      PhD student 2016-2019

      Image alt
      Clinical Research Associate II at Thermo Fisher Scientific.

    • Katja Gassner, PhD

      PhD student 2019-2023 and postdoc 2024

      Image alt
      Postdoctoral researcher at IRB-Barcelona (Ana V. Lechuga-Vieco’s Lab), Barcelona. SP.

    • Laura Coll, PhD

      PhD student 2019-2022 and postdoc 2023-2025

      Image alt
      Field Application Specialist (NGS) at Palex. SP.

  • Research Assistants

    • Xavier Llobet, RA

      2018-2025

      Image alt
      Lab manager at Peptomyc, Barcelona. SP.

    • Laura Plata, RA

      2021-2022

      Image alt
      Project Manager at Vall d’Hebron Institute of Research (VHIR).

    • Miriam Tenorio, RA

      2025

      Image alt
      Laboratory technician at Universitat de Barcelona (Elisa Espinet’s Lab), Barcelona. SP.

  • Master Students

    • Ainhoa Juan López. Role of Ezetimibe (NPC1L1 inhibitor) in anchorage-independent survival in endometrial carcinoma. Universitat de Barcelona. Defense: 08/07/2025.
    • Laia Camats Gangonells. Exploring the role of WNK2 in endometrial cancer tumorigenesis, immune context and angiogenic signaling. Universitat de Barcelona. Defense: 10/07/2023.
    • Esther Guerra Fernández. Molecular alterations associated with vascular invasion in endometrial cancer. Universidad Rey Juan Carlos. Defense: 10/07/2023.
    • Eva Soler Solé. Characterization of anchorage-independent resistant cells in endometrial carcinoma. Universitat de Barcelona. Defense: 11/07/2022.
    • Eulàlia Noguera Delgado. In vitro screening of new E3 ligase inhibitors. Universitat Pompeu Fabra. Defense: 01/07/2022.
    • Adriana Núñez Robainas. Evaluation of ramelteon as an autophagy inducer and as an anticancer agent in endometrial cancer. Universitat Pompeu Fabra. Defense: 01/07/2021.
    • Lara Martínez Guillamón. Study of mechanisms related with the progression of endometrial cancer. Universitat de Barcelona. Defense: 12/07/2021.
    • James Peter Robson Hacking. Deciphering the role of ITCH as a mediator of Sorafenib resistance in endometrial cancer cells. Newcastle University. Defense: 01/06/2017.

  • Undergraduate Students (TFG)

    • Anna Gatell Puig. Role of NPC1L1 and NPC1 in endometrial cancer tumorigenesis. Universitat Autònoma de Barcelona. Defense: 16/08/2025.
    • Immaculada Sánchez Durá. DGAT1 inhibition as a novel antitumor strategy in endometrial cancer. Universitat de Barcelona. Defense: 08/07/2025.
    • Clàudia Margenat Arqué. Effects of pharmacological inhibition of HSPB1 on autophagy, vacuole formation and exposure of immune Damage-associated Molecular Patterns (DAMPs) in endometrial cancer cells. Universitat Ramon Llull/IQS. Defense: 25/06/2024.
    • Sandra Martínez Segura. Study of lipid metabolism alterations associated to ARID1A in endometrial cancer. Universitat de Barcelona. Defense: 09/07/2024.
    • Gemma Capó Florit. Study of sorafenib resistance in endometrial cancer cells. Universitat de Lleida. Defense: 03/07/2023.
    • Laia Camats Gangonells. Evaluation of digoxin and 5-aminolevulinic acid as potential treatments for endometrial cancer targeting autophagy induction. Universitat de Barcelona. Defense: 13/07/2022.
    • Annabel Stefkova Radilova. Targeting autophagy machinery and cytotoxicity with solifenacin succinate and vincristine in endometrial cancer. Universitat de Barcelona. Defense: 11/07/2022.
    • Barbara Ferrando Antequera. Generation of genetically modified cell lines for the study of autophagy in endometrial cancer. Universitat de Barcelona. Defense: 08/02/2021.
    • Eulàlia Noguera Delgado. Optimization and validation of the PremoTMAutophagy Tandem Sensor RFP-GFP-LC3b assay for autophagic flux measurement in endometrial cancer cells. Universitat Autònoma de Barcelona. Defense: 13/01/2021.
    • Jameika Eilz Mae Ramos. Regulation of MET by miR-424(322)/503 during somatic cell reprogramming. Newcastle University. Defense: 31/03/2018.
    • William Goddard and Christine Bradley. Identification of miR-424/503 targets in senescent cells. Newcastle University. Defense: 31/03/2017.